HUMA
Humacyte, Inc. · Healthcare
Director and 10% owner Brady W Dougan sold $12.7M of Humacyte, Inc.
Sold$12,675,000
$2.60Price
4,875,000Shares
−28%Stake
What HUMA did after the filing
- The stock from Thu, Jun 15 close, $3.35
- −2.1%
- S&P 500, same days
- +3.8%
Measured over 30 trading days, to the Jul 31 close.
Traded Tue, Jun 13. Filed Thu, Jun 15, 12:19 PM ET, during the session. Returns use the Jun 15 close and the Jul 31 close. Not investment advice.